USPTO serial 76220858
THERIFLASH
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JENKINS JR, CHARLES L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THERIFLASH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Princeton, NJ
Princeton, NJ
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dissolving pills, tablets and lozenges delivered by mouth for the treatment of various diseases and conditions in humans or animals, namely, asthma, chronic obstructive pulmomary disease (CORD) and other diseases of the pulmonary system; hypertension, atherosclerosis, arrythmias, coagulation disorders, congestive heart failure and other diseases of the circulatory system, namely, the management of lipids and other risk factors; wound healing and closure, antiadhesion, and other treatment secondary to surgical procedures or diseases of the soft tissue; infectious diseases; tissue and organ transplantation; bone grafting, bone augmentation, fracture repair and other conditions of the muscoloskeletal system; cancer; mental disorders, epilepsy, Parkinson, attention deficit disorder, Alzheimer and other diseases of the central nervous system; gastrointestinal disorders; pain, localized and neuropathic; diabetes, thyroid disorders and other disorders of the endocrine system; infertility, endometriosis and other conditions of the female reproductive system; impotence and other disorders of the male reproductive system; lupus, and other disorders of the immune system; smoking cessation and other behavioral modification treatments; vitamin and other nutrient deficiencies; allergies; nausea; amyotrophic lateral sclerosis; dissolving gelatin capsules sold empty for pharmaceuticals; transdermal patches comprised of organic or synthetic materials for the timed release of pharmaceuticals or medicines | ACTIVE | — |
| 010 | Drug delivery implants | ACTIVE | — |
| 030 | Candy, chocolate coated candy, mints | ACTIVE | — |
| 040 | Manufacture of pharmaceuticals, implants, tissue growth matrices, scaffolds, three dimensional biological models, oral and transdermal drug devices to the order and specification of others; manufacture of general product lines in the fields of pharmaceuticals, orthopedic, dentistry, transplants, biomedical research and medicine to the order and specification of others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Therics, Inc.
- Other trademarks owned by Therics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 030
- Other trademarks in Class 040
- Similar marks named THERIFLASH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2004 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 16, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 9, 2004 | CFIT | CASE FILE IN TICRS | — |
| Dec 16, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 23, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 30, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 18, 2003 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 6, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 17, 2003 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 17, 2003 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Mar 5, 2003 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 25, 2003 | PAPER RECEIVED | — | |
| Feb 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 1, 2002 | REIN | REINSTATED | — |
| May 6, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2002 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 17, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2001 | DOCK | ASSIGNED TO EXAMINER | — |